|
Costs and benefits of HAART for patients with HIV in a public hospital in Mexico |
Aracena-Genao B, Navarro J O, Lamadrid-Figueroa H, Forsythe S, Trejo-Valdivia B |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Aracena-Genao B, Navarro J O, Lamadrid-Figueroa H, Forsythe S, Trejo-Valdivia B. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico. AIDS 2008; 22 (Supplement 1): S141-S148 Indexing Status Subject indexing assigned by NLM MeSH Adult; Anti-Retroviral Agents /economics /therapeutic use; Antiretroviral Therapy, Highly Active /economics; Cost-Benefit Analysis; Female; Follow-Up Studies; HIV Infections /drug therapy /economics /mortality; HIV-1; Hospitals, Public; Humans; Male; Mexico; Middle Aged; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Time AccessionNumber 22008102460 Date bibliographic record published 31/03/2009 |
|
|
|